Compositions and methods for increasing athletic performance
AssigneeVDF Futureceuticals, Inc.
InventorZbigniew Pietrzkowski
Life of this patent
Estimating the term…
Abstract
Compositions, methods, and uses are contemplated in which a betalain-containing preparation is administered to a mammal to enhance athletic performance. Most preferably, the preparations are substantially nitrate free and acutely and transiently increase hematocrit, erythropoietin, adrenalin, and beta endorphin, while reducing serum lactate, serum lactate dehydrogenase, heart rate and a rate of perceived exertion.
Claims23
A method of providing a nutraceutical stimulant to cause acute and transient increase of an exercise enhancing factor in an athlete in response to physical exercise comprising:
- providing a plurality of distinct betalains from a starting material;
- formulating the plurality of distinct betalains into a dosage unit suitable for oral administration;
- administering or causing to administer the dosage unit to the athlete before initiation of said physical exercise, effective to increase the exercise enhancing factor of the athlete acutely and transiently during or after exercise;
- wherein the exercise enhancing factor is selected from the group consisting of adrenalin, hematocrit, erythropoietin, and beta endorphin;
- and
- wherein the dosage unit comprises less than 1 wt % nitrate.
A method of reducing an exercise-related physical strain measure of an individual comprising:
- providing a plurality of distinct betalains from a starting material;
- formulating the plurality of distinct betalains into a dosage unit suitable for oral administration;
- administering or causing to administer the dosage unit to the individual effective to reduce the exercise-related physical strain measure;
- wherein the exercise-related physical strain measure is at least one of an exercise-induced increase in heart rate and a rate of perceived exertion (RPE).
A method of acutely accentuating an exercise-induced parameter in an individual:
- formulating a plurality of distinct betalains into a dosage unit suitable for oral administration;
- and
- administering or causing to administer the dosage unit to the individual effective to achieve at least one of the following:
- (i) accentuating an increase in the exercise-induced parameter of the individual, in which case the exercise-induced parameter is selected from the group consisting of adrenalin, hematocrit, erythropoietin, and beta endorphin, or (ii) accentuating a decrease in the exercise-induced parameter of the individual, in which case the exercise-induced parameter is selected from the group consisting of heart rate, serum lactate, and serum lactate dehydrogenase,
- wherein the exercise induced parameter is not accentuated when the individual does not exercise.
Dependencies are inferred from the claim text.